Although recent experimental treatments have not produced any new drugs, they have still helped scientists learn more about the brain and the disease, Snyder said. Scientists begin to understand that a person's brain is beginning to change in a decade or so before being diagnosed with Alzheimer's disease.
"We are absolutely committed to ensuring that no stone is overcharged and that all roads are pursued," Snyder said. "We are optimistic that our understanding of science continues to grow and move forward, our ability to both target the various biologies, but also to combine some of these pieces together," adds.
Borghoffs called a family meeting Thursday evening. Jeff, positive as always, said he wanted to find another clinical trial to sign up so he could help scientists find a treatment or cure that could help their children or grandchildren.
Kim wants him to try medical marijuana or CBD oil. She hopes these options can choke the anxiety and anger Jeff is experiencing increasingly. However, it has also not been approved by the FDA to treat or treat Alzheimer's or other dementia, nor have they been evaluated in clinical trials. It is also unclear how people with dementia will respond to the psychoactive effects of marijuana or how it will interact with the other drugs used to treat the desease.
"I still look at all the possibilities and all the angles. I am of the philosophy that a box has six pages, and I can only see three sides at a time," said Jeff Borghoff. "There are other perspectives to look at and other things to pay attention to."